vs

Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Terra Property Trust, Inc. (TPTA). Click either name above to swap in a different company.

Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $7.1M, roughly 1.3× Terra Property Trust, Inc.). Terra Property Trust, Inc. runs the higher net margin — -150.2% vs -234.3%, a 84.1% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -37.4%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -31.3%).

Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.

The National Savings and Trust Company is a historic bank building located at the corner of New York Avenue and 15th Street, NW in Downtown Washington, D.C. It has also been known as the National Safe Deposit Company and the National Safe Deposit Savings and Trust Company.

FHTX vs TPTA — Head-to-Head

Bigger by revenue
FHTX
FHTX
1.3× larger
FHTX
$9.2M
$7.1M
TPTA
Growing faster (revenue YoY)
FHTX
FHTX
+261.1% gap
FHTX
223.8%
-37.4%
TPTA
Higher net margin
TPTA
TPTA
84.1% more per $
TPTA
-150.2%
-234.3%
FHTX
Faster 2-yr revenue CAGR
FHTX
FHTX
Annualised
FHTX
35.3%
-31.3%
TPTA

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FHTX
FHTX
TPTA
TPTA
Revenue
$9.2M
$7.1M
Net Profit
$-21.7M
$-10.6M
Gross Margin
Operating Margin
-258.2%
-48.8%
Net Margin
-234.3%
-150.2%
Revenue YoY
223.8%
-37.4%
Net Profit YoY
-11.1%
32.0%
EPS (diluted)
$-0.35
$-0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FHTX
FHTX
TPTA
TPTA
Q4 25
$9.2M
$7.1M
Q3 25
$8.2M
$7.3M
Q2 25
$7.6M
$8.6M
Q1 25
$6.0M
$12.5M
Q4 24
$2.9M
$11.3M
Q3 24
$7.8M
$12.2M
Q2 24
$6.9M
$11.2M
Q1 24
$5.0M
$15.0M
Net Profit
FHTX
FHTX
TPTA
TPTA
Q4 25
$-21.7M
$-10.6M
Q3 25
$-15.8M
$-6.7M
Q2 25
$-17.9M
$-9.2M
Q1 25
$-18.8M
$-1.3M
Q4 24
$-19.5M
$-15.6M
Q3 24
$-19.1M
$-7.8M
Q2 24
$-23.0M
$-7.5M
Q1 24
$-25.0M
$-6.2M
Operating Margin
FHTX
FHTX
TPTA
TPTA
Q4 25
-258.2%
-48.8%
Q3 25
-226.9%
6.7%
Q2 25
-279.2%
-28.4%
Q1 25
-385.0%
32.8%
Q4 24
-840.5%
-72.3%
Q3 24
-305.5%
54.1%
Q2 24
-386.6%
6.3%
Q1 24
-558.3%
32.0%
Net Margin
FHTX
FHTX
TPTA
TPTA
Q4 25
-234.3%
-150.2%
Q3 25
-194.4%
-92.4%
Q2 25
-237.3%
-106.5%
Q1 25
-316.4%
-10.3%
Q4 24
-682.9%
-138.3%
Q3 24
-244.9%
-63.9%
Q2 24
-333.6%
-67.5%
Q1 24
-495.4%
-41.2%
EPS (diluted)
FHTX
FHTX
TPTA
TPTA
Q4 25
$-0.35
$-0.43
Q3 25
$-0.25
$-0.28
Q2 25
$-0.28
$-0.38
Q1 25
$-0.30
$-0.05
Q4 24
$-0.23
$-0.65
Q3 24
$-0.31
$-0.32
Q2 24
$-0.45
$-0.31
Q1 24
$-0.59
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FHTX
FHTX
TPTA
TPTA
Cash + ST InvestmentsLiquidity on hand
$80.9M
$33.2M
Total DebtLower is stronger
$178.9M
Stockholders' EquityBook value
$-108.5M
$146.5M
Total Assets
$198.1M
$351.5M
Debt / EquityLower = less leverage
1.22×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FHTX
FHTX
TPTA
TPTA
Q4 25
$80.9M
$33.2M
Q3 25
$89.3M
$17.4M
Q2 25
$72.6M
$5.9M
Q1 25
$61.0M
$11.9M
Q4 24
$55.5M
$8.6M
Q3 24
$57.7M
$21.2M
Q2 24
$138.9M
$18.9M
Q1 24
$79.3M
$17.9M
Total Debt
FHTX
FHTX
TPTA
TPTA
Q4 25
$178.9M
Q3 25
$211.9M
Q2 25
$260.2M
Q1 25
$286.7M
Q4 24
$326.1M
Q3 24
$312.9M
Q2 24
$383.8M
Q1 24
$377.6M
Stockholders' Equity
FHTX
FHTX
TPTA
TPTA
Q4 25
$-108.5M
$146.5M
Q3 25
$-89.7M
$159.7M
Q2 25
$-76.7M
$168.5M
Q1 25
$-61.7M
$179.9M
Q4 24
$-45.5M
$185.7M
Q3 24
$-28.3M
$206.2M
Q2 24
$-14.3M
$218.6M
Q1 24
$-97.5M
$230.5M
Total Assets
FHTX
FHTX
TPTA
TPTA
Q4 25
$198.1M
$351.5M
Q3 25
$205.0M
$398.1M
Q2 25
$226.2M
$459.3M
Q1 25
$258.7M
$495.2M
Q4 24
$284.0M
$542.8M
Q3 24
$308.4M
$546.8M
Q2 24
$328.6M
$634.4M
Q1 24
$255.0M
$640.2M
Debt / Equity
FHTX
FHTX
TPTA
TPTA
Q4 25
1.22×
Q3 25
1.33×
Q2 25
1.54×
Q1 25
1.59×
Q4 24
1.76×
Q3 24
1.52×
Q2 24
1.76×
Q1 24
1.64×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FHTX
FHTX
TPTA
TPTA
Operating Cash FlowLast quarter
$-22.3M
$1.9M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FHTX
FHTX
TPTA
TPTA
Q4 25
$-22.3M
$1.9M
Q3 25
$-18.9M
$-4.3M
Q2 25
$-21.0M
$1.2M
Q1 25
$-24.0M
$861.6K
Q4 24
$-24.5M
$-3.3M
Q3 24
$-21.0M
$1.7M
Q2 24
$-25.5M
$-3.1M
Q1 24
$-29.3M
$-4.2M
Free Cash Flow
FHTX
FHTX
TPTA
TPTA
Q4 25
Q3 25
Q2 25
$-21.0M
Q1 25
$-24.0M
Q4 24
$-25.0M
Q3 24
$-21.3M
Q2 24
$-25.6M
Q1 24
$-29.4M
FCF Margin
FHTX
FHTX
TPTA
TPTA
Q4 25
Q3 25
Q2 25
-278.2%
Q1 25
-403.2%
Q4 24
-875.3%
Q3 24
-273.0%
Q2 24
-371.0%
Q1 24
-583.1%
Capex Intensity
FHTX
FHTX
TPTA
TPTA
Q4 25
0.0%
Q3 25
0.0%
Q2 25
0.3%
Q1 25
0.5%
Q4 24
16.8%
0.0%
Q3 24
4.0%
Q2 24
0.2%
Q1 24
2.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons